Systemic impairment in relation to disease burden in patients with moderate COPD eligible for a lifestyle program. Findings from the INTERCOM trial

INTRODUCTION: In contrast with the frequency distribution of chronic obstructive pulmonary disease (COPD) stages in the population, in which the majority of the patients is classified as GOLD 2, much less information is available on the prevalence and implications of systemic manifestations in less...

Descripción completa

Detalles Bibliográficos
Autores principales: van Wetering, Carel R, van Nooten, Floortje E, Mol, Stijn J M, Hoogendoorn, Martine, Rutten-van Mölken, Maureen P M H, Schols, Annemie M
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629991/
https://www.ncbi.nlm.nih.gov/pubmed/18990973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629991/
https://www.ncbi.nlm.nih.gov/pubmed/18990973

Ejemplares similares